TGTX
USDTG Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$33.070
High
$34.325
Low
$32.772
Volume
1.47M
Company Fundamentals
Market Cap
5.4B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.11M
Exchange
NCM
Currency
USD
52-Week Range
Related News
JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $49
JP Morgan analyst Eric Joseph maintains TG Therapeutics with a Overweight and raises the price target from $46 to $49.
TG Therapeutics Reports Third Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance
Third quarter 2025 total revenue of $161.7 million, including BRIUMVI U.S. net revenue of $152.9 million Raises full year 2025 global revenue target to $600 million, and raises full year BRIUMVI U.S. net revenue target
TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update
NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced that a conference call will be held, Monday, November 3, 2025, at 8:30 AM ET to discuss results for the third quarter of
TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), announced today that enrollment has completed in the randomized cohort of the Phase 3 ENHANCE trial evaluating a consolidated Day 1 and
Related Stocks
BPOPM
Popular Inc. Popular Capital Trust II - 6.125% Cumulative Monthly Income Trust Preferred Securities
FCAP
First Capital Inc.
DOW
Dow Inc.
EQH
Equitable Holdings Inc.
ALC
Alcon Inc. Ordinary Shares
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.